IRVINE, Calif., May 12, 2025 (GLOBE NEWSWIRE) -- Oncocyte Corp. (Nasdaq: OCX), a diagnostics technology company, today published the following letter to shareholders in conjunction with its first quarter results:
Oncocyte Reports Q1 2025 Results and Business Progress
Seeking Alpha / 15 hours ago 1 Views
Comments